Open access
Open access
Powered by Google Translator Translator

Phase 2 RCT | Peresolimab outperforms placebo in patients with moderate-to-severe rheumatoid arthritis

24 May, 2023 | 13:07h | UTC

A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Peresolimab Demonstrates Efficacy in Treating Patients With Rheumatoid Arthritis – HCP Live


Commentary on Twitter


Stay Updated in Your Specialty

Telegram Channels

WhatsApp alerts US$ 7.00/month

No spam, just news.